A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)

Clinical trial NCT05321069 · COMPLETED

Trial details

NCT number: NCT05321069
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Idiopathic Pulmonary Fibrosis

Start date: 2022-10-06
Primary completion: 2024-08-16
Enrollment: 1177

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.